Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

2.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

3.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

4.

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

5.

How AI will transform mental health support for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot